KOMP ETF Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

KOMP Analyst Ratings

Moderate Buy

346 Buy

91 Hold

14 Sell

Based on the consensus analyst ratings on 451 stocks held in KOMP.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

KOMP 12 Month Forecast

Average Price Target

$61.83

Based on the average price target on 451 stocks. Derived from Wall Street analysts offering 12-month price targets on KOMP holdings in the last 3 months. The average price target is $61.83 with a high forecast of $75.16 and a low forecast of $49.68. The average price target represents a 11.01% change from the last price of $55.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"44":"$44","52":"$52","60":"$60","68":"$68","76":"$76"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":75.163,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$75.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61.831,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$61.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.681,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$49.68</span>\n  </div></div>","useHTML":true}}],"tickPositions":[44,52,60,68,76],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.38,55.97869230769231,57.57738461538462,59.17607692307693,60.77476923076923,62.37346153846154,63.972153846153844,65.57084615384615,67.16953846153847,68.76823076923077,70.36692307692307,71.96561538461538,73.5643076923077,{"y":75.163,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.38,54.953153846153846,55.5263076923077,56.09946153846154,56.67261538461539,57.245769230769234,57.81892307692308,58.39207692307693,58.96523076923077,59.538384615384615,60.111538461538466,60.68469230769231,61.25784615384616,{"y":61.831,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.38,54.01853846153846,53.65707692307692,53.29561538461539,52.93415384615385,52.57269230769231,52.21123076923077,51.84976923076923,51.48830769230769,51.12684615384615,50.76538461538461,50.40392307692308,50.04246153846154,{"y":49.681,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.35,"date":1719792000000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.86,"date":1722470400000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.26,"date":1725321600000,"info":"<div>Price: <b>$46<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":48.34,"date":1727740800000,"info":"<div>Price: <b>$48<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":49.06,"date":1730419200000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53.92,"date":1733097600000,"info":"<div>Price: <b>$54<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":50.74,"date":1735776000000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.59,"date":1738540800000,"info":"<div>Price: <b>$53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":48.83,"date":1740960000000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.73,"date":1743465600000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.82,"date":1746057600000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":50.3,"date":1748822400000,"info":"<div>Price: <b>$50<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":54.38,"date":1751328000000,"info":"<div>Price: <b>$54<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$75.16

Average Price Target$61.83

Lowest Price Target$49.68

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

KOMP Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IOVA

Iovance Biotherapeutics

7 Buy

4 Hold

0 Sell

Moderate Buy

$10.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RGNX

RegenXBio Inc.

8 Buy

1 Hold

0 Sell

Strong Buy

$32.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RCKT

Rocket Pharma

10 Buy

7 Hold

1 Sell

Moderate Buy

$10.37

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TSHA

Taysha Gene Therapies, Inc.

11 Buy

0 Hold

0 Sell

Strong Buy

$8.35

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VIR

Vir Biotechnology, Inc.

7 Buy

2 Hold

0 Sell

Strong Buy

$18.14

KOMP Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF

Please check back later or explore other ETFs for potential investment opportunities.

KOMP ETF FAQ

What is KOMP’s average 12-month price target, according to analysts?

Based on analyst ratings, KOMP’s 12-month average price target is 61.83.

What is KOMP’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for KOMP, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is KOMP a Buy, Sell or Hold?

KOMP has a consensus rating of Moderate Buy which is based on 346 buy ratings, 91 hold ratings and 14 sell ratings.

What is KOMP’s price target?

The average price target for KOMP is 61.83. This is based on 451 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $75.16 ,the lowest forecast is $49.68. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about KOMP?

KOMP’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 451 Wall Streets Analysts.

How can I buy shares of KOMP?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing